| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TTD | Class A Common Stock | Options Exercise | $201K | +7.37K | +3.58% | $27.24 | 214K | Nov 1, 2021 | Direct | |
| transaction | TTD | Class A Common Stock | Options Exercise | $72.3K | +2.65K | +1.24% | $27.24 | 216K | Nov 1, 2021 | Direct | |
| transaction | TTD | Class A Common Stock | Options Exercise | $198K | +6.58K | +3.04% | $30.00 | 223K | Nov 1, 2021 | Direct | |
| transaction | TTD | Class A Common Stock | Sale | -$891K | -12K | -5.36% | $74.54 | 211K | Nov 1, 2021 | Direct | F1, F2 |
| transaction | TTD | Class A Common Stock | Sale | -$350K | -4.66K | -2.21% | $75.17 | 206K | Nov 1, 2021 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TTD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -7.37K | -5.02% | $0.00 | 139K | Nov 1, 2021 | Class A Common Stock | 7.37K | $27.24 | Direct | F4 |
| transaction | TTD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -2.65K | -5.11% | $0.00 | 49.3K | Nov 1, 2021 | Class A Common Stock | 2.65K | $27.24 | Direct | F5 |
| transaction | TTD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -6.58K | -9.5% | $0.00 | 62.7K | Nov 1, 2021 | Class A Common Stock | 6.58K | $30.00 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.10 to $75.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.10 to $75.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F4 | The option was granted on December 27, 2019. The Vesting Commencement Date ("VCD") was December 16, 2019. One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. |
| F5 | The option was granted on December 27, 2019. The VCD was December 16, 2019. One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. |
| F6 | The option was granted on May 15, 2020, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. |